Chargement de la fiche…
Chargement de la fiche…
Praticien hospitalier
Photo : Benjamin Smith, CC BY-SA 4.0, Wikimedia Commons
Dans les médias
Vous êtes Dr Nicolas Richard ? Présentation, expertises, actes, site du cabinet : faites de cette fiche la page de votre cabinet.
Configurer votre fiche gratuitement →Dr Nicolas Richard est rhumatologue à Chalon-sur-Saône (71321). Il consulte à CH WILLIAM MOREY CHALON SUR SAONE, 4 Rue CAPITAINE DRILLIEN, 71321 Chalon-sur-Saône.
Consulter
CH WILLIAM MOREY CHALON SUR SAONE
4 Rue CAPITAINE DRILLIEN, 71321 Chalon-sur-Saône
Dr Nicolas Richard, c'est vous ?
Faites de cette fiche la page de votre cabinet.
Hospitalier
Pour aller plus loin
Remboursement
Pratique
Thèmes de publication
Domaines déduits des publications référencées sur PubMed.
Faits issus de registres publics et des déclarations du praticien — aucun classement.
Rhumatologie (SM) — Diplôme d'études spécialisées
CES Rhumatologie · DE Docteur en médecine — Capacité / certificat d'études spéciales
Les plus citées
2024The Lancet regional health. Europe28 citations
Incidence, prevalence and clinical presentation of inflammatory bowel diseases in Northern France: a 30-year population-based study
2023World journal of gastroenterology27 citations
Crohn's disease: Why the ileum?
2025Gut23 citations
Top-down infliximab plus azathioprine versus azathioprine alone in patients with acute severe ulcerative colitis responsive to intravenous steroids: a parallel, open-label randomised controlled trial, the ACTIVE trial
Contenus publics où le nom du praticien apparaît (YouTube, Google Actualités).
En bref
Dr Nicolas Richard consulte à CH WILLIAM MOREY CHALON SUR SAONE, 4 Rue CAPITAINE DRILLIEN, 71321 Chalon-sur-Saône. Adresses issues de l'Annuaire Santé (ANS).
Par téléphone au 03 85 44 66 88 (numéro publié à l'Annuaire Santé). Un lien de recherche Doctolib est proposé sur cette page : si le praticien y est inscrit, son profil figure normalement parmi les résultats.
Identité, diplômes et lieux d'exercice : Annuaire Santé (ANS, licence ouverte). Conventionnement et carte Vitale : Assurance Maladie. Publications : bases scientifiques publiques (PubMed, HAL, OpenAlex), affichées seulement si le nom du praticien figure parmi les auteurs. Le praticien peut corriger sa fiche ou en demander le retrait à tout moment ; en cas d'homonymie, signalez-le.
Autour du cabinet
Rhumatologues à Chalon-sur-Saône →Rhumatologues en Saône-et-Loire (71) →
Vous pouvez aussi demander le retrait de la fiche.
Aperçu de votre présentation
Rhumatologue à Chalon-sur-Saône, j'accompagne…
Exemple : vous choisissez vos propres domaines.
Association of bowel urgency, disease activity and disability in patients with inflammatory bowel disease: A cross-sectional study from the GETAID
2026Alimentary pharmacology & therapeuticsPubMed
Letter: Upadacitinib in Perianal Crohn's Disease: Does Clinical Closure Reflect True Remission? Authors' Reply
2026Alimentary pharmacology & therapeuticsPubMed
Editorial: Upadacitinib in Perianal Crohn's Disease. Authors' Reply
2026Alimentary pharmacology & therapeuticsPubMed
One-Year Effectiveness of Upadacitinib in Perianal Crohn's Disease: A Real-World GETAID Study
2025Alimentary pharmacology & therapeuticsPubMed
Effectiveness and Safety of a Second JAK Inhibitor in Ulcerative Colitis: The J2J Multicentre Study
2025Alimentary pharmacology & therapeuticsPubMed
Editorial: Real-World Evidence of Upadacitinib-An Effective Induction Therapy for Crohn's Disease? Authors' Reply
2025Alimentary pharmacology & therapeuticsPubMed
Effectiveness and Safety of Upadacitinib Induction Therapy for 223 Patients With Crohn's Disease: A GETAID Multicentre Cohort Study
2024Rheumatology and therapyPubMed
Real-World Effectiveness of Upadacitinib for Treatment of Rheumatoid Arthritis in Canadian Patients: Interim Results from the Prospective Observational CLOSE-UP Study
2026Journal of pediatric gastroenterology and nutritionPubMed
Chronic conditions associated with paediatric onset inflammatory bowel diseases: A population-based study
2026Clinics and research in hepatology and gastroenterologyPubMed
Incidence and Neoplastic Risk Associated with Colonic Stricture in Paediatric-Onset Crohn's Disease: A Population-based Study
2025Inflammatory bowel diseasesPubMed
Long-Term Outcome of Colonic and Ileal Crohn's Disease: A Two-Decade Population-Based Study in Pediatric-Onset Disease
2025Diseases of the colon and rectumPubMed
Natural History of Anal Strictures in Pediatric-Onset Crohn's Disease: Long-term Follow-up of a Population-Based Study
2025Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the LiverPubMed
Incidence and risk factors for thromboembolic events in pediatric-onset inflammatory bowel disease: A French population-based study
2021BMC pediatricsPubMed
Hordeum murinum aspiration revealed by a pneumopleurocutaneous fistula in a 15-month-old infant
2026The Journal of rheumatologyPubMed
Canadian Rheumatology Association/Spondyloarthritis Research Consortium of Canada Living Treatment Recommendations for the Management of Axial Spondyloarthritis: Update #1
2025The Journal of rheumatologyPubMed
Residual Disease Activity and Burden of Disease in Canadian Patients With Axial Spondyloarthritis: Results From a Multiregistry Analysis (UNISON-Axial SpA)
2025Rheumatology advances in practicePubMed
Impact of disease manifestations on first biologic drug survival in axial spondyloarthritis: a real-life Canadian study
2025The Journal of rheumatologyPubMed
Canadian Rheumatology Association/Spondyloarthritis Research Consortium of Canada Living Treatment Recommendations for the Management of Axial Spondyloarthritis
2022Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseasesPubMed
First Biologic Drug Persistence in Patients With Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis: A Real-World Canadian Physicians' Experience
2026Clinics and research in hepatology and gastroenterologyPubMed
Incidence and Neoplastic Risk Associated with Colonic Stricture in Paediatric-Onset Crohn's Disease: A Population-based Study
2025Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological AssociationPubMed
Risk of Incident Cancer in Patients With Inflammatory Bowel Disease With Prior Breast Cancer: A Multicenter Cohort Study
2025Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the LiverPubMed
Incidence and risk factors for thromboembolic events in pediatric-onset inflammatory bowel disease: A French population-based study
2024The Lancet regional health. EuropePubMed
Incidence, prevalence and clinical presentation of inflammatory bowel diseases in Northern France: a 30-year population-based study
2026The American journal of gastroenterologyPubMed
Subcutaneous Infliximab for Perianal Crohn's Disease: The BioLap-Rem Multicenter Study From the GETAID
2025GutPubMed
Top-down infliximab plus azathioprine versus azathioprine alone in patients with acute severe ulcerative colitis responsive to intravenous steroids: a parallel, open-label randomised controlled trial, the ACTIVE trial
2026 · Article
Chronic conditions associated with paediatric onset inflammatory bowel diseases: A population‐based study
2026 · Article
Letter: Upadacitinib in Perianal Crohn's Disease: Does Clinical Closure Reflect True Remission? Authors' Reply
2026 · Article
Abnormal position of a GNAS methylation regulatory element causes autosomal dominant pseudohypoparathyroidism type 1B (PHP1B)
2026 · Article
Editorial: Upadacitinib in Perianal Crohn's Disease. Authors' Reply
2026 · Article
Association of bowel urgency, disease activity and disability in patients with inflammatory Bowel Disease: A cross-sectional study from the GETAID
2026 · Article
One‐Year Effectiveness of Upadacitinib in Perianal Crohn's Disease: A Real‐World GETAID Study
2026 · Article
Incidence and Neoplastic Risk Associated with Colonic Stricture in Paediatric-Onset Crohn's Disease: A Population-based Study
2026 · Article
Influence of CYP2D6 phenotype on the pharmacokinetics and pharmacodynamics of tramadol in patients treated for post-operative pain management
Publications affichées uniquement lorsque le nom du praticien figure parmi les auteurs. Une erreur d'homonymie ? Signalez-la depuis le lien en bas de page.